CGEMCULLINAN THERAPEUTICS INC
CUSIP 230031106 · common stock
1 tracked investor held CULLINAN THERAPEUTICS INC (CGEM) at the end of Q3 2026, worth $12.3M. The largest holder was Ken Fisher, with 0.0% of its portfolio. Perceptive Advisors sold out of its position this quarter.
Holders · Q3 2026
1
New holders
0
Value held
$12.3M
Quarter-end price (est.)
$15.35
Investors holding CGEM · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Ken Fisher Fisher Asset Management, LLC | 0.00% | 800,961 | $12.3M | ADD+2,125.0% |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Perceptive Advisors | 0.12% | 426,478 | $7.8M | EXIT |
History
| Quarter | Holders | New | Sold out | Value held | Quarter-end price (est.) |
|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 1 | $12.3M | $15.35 |
| Q2 2026 | 2 | 2 | 1 | $8.4M | $18.21 |
| Q1 2026 | 1 | 0 | 0 | $710.5K | $14.21 |
| Q4 2025 | 1 | 0 | 0 | $517.5K | $10.35 |
| Q4 2022 | 0 | 0 | 1 | $0 | — |
| Q3 2022 | 1 | 0 | 0 | $5.5M | $12.82 |
| Q2 2022 | 1 | 0 | 0 | $19.7M | $12.82 |
| Q1 2022 | 1 | 0 | 0 | $16.1M | $10.47 |
| Q4 2021 | 1 | 0 | 0 | $22.5M | $14.66 |
| Q3 2021 | 1 | 0 | 0 | $40.2M | $21.92 |
| Q2 2021 | 1 | 0 | 0 | $46.3M | $25.21 |
| Q1 2021 | 1 | 1 | 0 | $71.7M | $39.06 |